NVIDIA Revolutionizes the World of Drug Discovery and Design
NVIDIA made waves when founder and CEO Jensen Huang spoke at the annual J.P. Morgan Healthcare Conference, declaring, “This is the generative AI revolution.” The technology giant is taking the field of drug discovery out of the laboratory and into the realm of computer simulation. It’s AI-accelerated drug design, and NVIDIA is at the forefront of creating this brave new world.
Generative AI and NVIDIA Usability
NVIDIA’s involvement in accelerated healthcare stems from years of research and development in the field of computer-aided chip design. The company has recognized that the same technology that powers computer chip design can play a huge role in the world of drug discovery. Imagine the possibilities when biology can be simulated a billion times over in a virtual world.
Collaborating on the Future of Drug Discovery
NVIDIA is using state-of-the-art AI models and powerful computing platforms to move the field of drug discovery forward. The company is building pipelines that will advance everything from gene sequencing to virtual drug molecule screening. In the near future, we could see huge advancements in drug development thanks to these computing tools.
This transformation to a software-defined, AI-driven industry will also advance medical instruments. “Everybody is a programmer, and the programming language of the future is called ‘human,’” according to Huang. “A medical instrument is never going to be the same again.”
Join the Discussion
What do you think of the future of drug discovery and AI-driven health technology? Tell us your thoughts.
IntelliPrompt curated this article: Read the full story at the original source by clicking here